Clinical Trial Update: Quality Assurance of Administering Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD) - QUMEA [Phase 3]

View source ↗

Summary

This document provides a Phase 3 clinical trial update focusing on quality assurance for administering methylphenidate to adults with Attention-Deficit/Hyperact…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Medice Arzneimittel Pütter GmbH & Co KG | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED